STEELDERM
ActiveSummary
STEELDERM has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €201,239 and a net result of €81,081. Equity is growing by about 32% per year across the filed financial years. Its solvency ranks better than 24% of 20,620 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
28-08
NBB filing
Annual accounts filed
financial year 2025 · micro format · 28 days late
2025
31-12
Financial
Highest result from 2020 to 2025net €81,081 ▲10.7%
Operating result €105,912, net result €81,081, both a record.
28-08
NBB filing
Annual accounts filed
financial year 2024 · micro format · 28 days late
2024
31-12
Financial
Equity above €200,000equity €204,558 ▲55.8%
A profit in every financial year since 2020 builds equity to €204,558.
30-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 30 days late
2023
31-12
Financial
Equity above €100,000equity €131,305 ▲54.7%
A profit in every financial year since 2020 builds equity to €131,305.
31-08
NBB filing
Annual accounts filed
financial year 2022 · micro format · 31 days late
2022
29-07
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
31-12
Financial
Weakest financial yearnet €15,914 ▼62.2%
Net result drops to €15,914, the lowest in the series; recovery starts the following year.
31-08
NBB filing
Annual accounts filed
financial year 2020 · micro format · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.